The test have been done in vivo and in vitro on lab animals and in human cancer cells. From the tests done so far, there were zero side effects. I believe this is becasue FAS is only found and active in the liver, adipose tissue, and in the brain as a regulator of appitite and such. An inhibitor of FAS should only be active in those organs, and that is what was observed.....the only "side effects" in the testing against cancer was weightloss (drastic) and extreme appitite supression. So it seems this drug can have a limited scope and target tissues...
I dont know where the %50 increase in BMR came from, but i dont see why it isnt possible.....DNP increases metabolism to that amount without CNS stimulation, (but releases the H+ as entropy).....what i would question is where the ATP being made is going to be expended?????
So far, it seems as if malonyl-CoA is the key......with inhibition of fatty acid, this molecule (also plays a part in fatty acid synthesis) builds up and acts as FFA in the brain telling the body its well fed and metabolism can proceed at %100. The doctors feel that the molecule also might act in anotherway to increase metabolism.
I agree with you Fonz, im not saying its a magic pill, but what has been observed shows great promise. All the research is geared toward a drug for humans, a chemicaly stabe inhibitor, completly synthetic. Wakil is working on a human drug minus the appitite supression (i dont know how hes going to do it, it seems to be key in triggering weight loss). Ive given up on brown adipose tissue manipulation, it just seemed too out of reach....unless you have things to share....!
I guess the combination of a big caloric deficit and a metabolism at %100 (no starvation mode is very key in this) could give results that are as amazing as a %50 increase in BMR......i mena thats why diets are only partially effective....when you have a caloric defecit, your body senses this and slows metabolism.